These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22279706)

  • 21. The role of bundles in sepsis care.
    Hurtado FJ; Nin N
    Crit Care Clin; 2006 Jul; 22(3):521-9, x. PubMed ID: 16893737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of sepsis in the critically ill patient: key aspects.
    Vincent JL
    Expert Opin Pharmacother; 2006 Oct; 7(15):2037-45. PubMed ID: 17020431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe sepsis and septic shock in the emergency department.
    Talan DA; Moran GJ; Abrahamian FM
    Infect Dis Clin North Am; 2008 Mar; 22(1):1-31, v. PubMed ID: 18295681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing mortality in sepsis: new directions.
    Vincent JL; Abraham E; Annane D; Bernard G; Rivers E; Van den Berghe G
    Crit Care; 2002 Dec; 6 Suppl 3(Suppl 3):S1-18. PubMed ID: 12720570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Novel treatment for severe sepsis: recombinant human protein C (RHAPC)].
    Uszyiński W; Uszyński M; Lisiecki A
    Ginekol Pol; 2005 Nov; 76(11):913-20. PubMed ID: 16566369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated protein C (Xigris) treatment in sepsis: a drug in trouble.
    Gårdlund B
    Acta Anaesthesiol Scand; 2006 Sep; 50(8):907-10. PubMed ID: 16923083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of severe sepsis: role of "bundles".
    Khilnani GC; Hadda V
    Indian J Chest Dis Allied Sci; 2009; 51(1):27-36. PubMed ID: 19317360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. An assessment by the Australian and New Zealand intensive care society.
    Hicks P; Cooper DJ; Webb S; Myburgh J; Seppelt I; Peake S; Joyce C; Stephens D; Turner A; French C; Hart G; Jenkins I; Burrell A
    Anaesth Intensive Care; 2008 Mar; 36(2):149-51. PubMed ID: 18361003
    [No Abstract]   [Full Text] [Related]  

  • 29. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
    Evans L; Rhodes A; Alhazzani W; Antonelli M; Coopersmith CM; French C; Machado FR; Mcintyre L; Ostermann M; Prescott HC; Schorr C; Simpson S; Wiersinga WJ; Alshamsi F; Angus DC; Arabi Y; Azevedo L; Beale R; Beilman G; Belley-Cote E; Burry L; Cecconi M; Centofanti J; Coz Yataco A; De Waele J; Dellinger RP; Doi K; Du B; Estenssoro E; Ferrer R; Gomersall C; Hodgson C; Hylander Møller M; Iwashyna T; Jacob S; Kleinpell R; Klompas M; Koh Y; Kumar A; Kwizera A; Lobo S; Masur H; McGloughlin S; Mehta S; Mehta Y; Mer M; Nunnally M; Oczkowski S; Osborn T; Papathanassoglou E; Perner A; Puskarich M; Roberts J; Schweickert W; Seckel M; Sevransky J; Sprung CL; Welte T; Zimmerman J; Levy M
    Crit Care Med; 2021 Nov; 49(11):e1063-e1143. PubMed ID: 34605781
    [No Abstract]   [Full Text] [Related]  

  • 30. [Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis].
    Heslet L; Nielsen JD; Schierbeck J; Andersen JS
    Ugeskr Laeger; 2004 Mar; 166(11):997-1002. PubMed ID: 15049234
    [No Abstract]   [Full Text] [Related]  

  • 31. Controversies of surviving sepsis campaign bundles: should we use them?
    Machado FR; Freitas FG
    Shock; 2008 Oct; 30 Suppl 1():34-40. PubMed ID: 18704011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practice and perception--a nationwide survey of therapy habits in sepsis.
    Brunkhorst FM; Engel C; Ragaller M; Welte T; Rossaint R; Gerlach H; Mayer K; John S; Stuber F; Weiler N; Oppert M; Moerer O; Bogatsch H; Reinhart K; Loeffler M; Hartog C;
    Crit Care Med; 2008 Oct; 36(10):2719-25. PubMed ID: 18766100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Severe sepsis treated with activated protein C].
    Frøyshov S; Jacobsen D; Bjertnaes L; Flaatten H
    Tidsskr Nor Laegeforen; 2004 Mar; 124(6):779-81. PubMed ID: 15039807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drotrecogin alfa (activated) in South African private hospital ICUs.
    Hodgson RE; Williams PG; Foden AP; Grolman D
    S Afr Med J; 2003 Jul; 93(7):474-5. PubMed ID: 12939910
    [No Abstract]   [Full Text] [Related]  

  • 35. Sepsis bundles and compliance with clinical guidelines.
    Stoneking L; Denninghoff K; Deluca L; Keim SM; Munger B
    J Intensive Care Med; 2011; 26(3):172-82. PubMed ID: 21670090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021.
    Evans L; Rhodes A; Alhazzani W; Antonelli M; Coopersmith CM; French C; Machado FR; Mcintyre L; Ostermann M; Prescott HC; Schorr C; Simpson S; Joost Wiersinga W; Alshamsi F; Angus DC; Arabi Y; Azevedo L; Beale R; Beilman G; Belley-Cote E; Burry L; Cecconi M; Centofanti J; Yataco AC; De Waele J; Dellinger RP; Doi K; Du B; Estenssoro E; Ferrer R; Gomersall C; Hodgson C; Møller MH; Iwashyna T; Jacob S; Kleinpell R; Klompas M; Koh Y; Kumar A; Kwizera A; Lobo S; Masur H; McGloughlin S; Mehta S; Mehta Y; Mer M; Nunnally M; Oczkowski S; Osborn T; Papathanassoglou E; Perner A; Puskarich M; Roberts J; Schweickert W; Seckel M; Sevransky J; Sprung CL; Welte T; Zimmerman J; Levy M
    Crit Care Med; 2021 Nov; 49(11):1974-1982. PubMed ID: 34643578
    [No Abstract]   [Full Text] [Related]  

  • 37. Should we be using activated protein C to treat severe sepsis?
    Eve RL; Duffy MR
    Br J Hosp Med (Lond); 2009 Aug; 70(8):484. PubMed ID: 19684544
    [No Abstract]   [Full Text] [Related]  

  • 38. Once is not enough: clinical trials in sepsis.
    Sweeney DA; Danner RL; Eichacker PQ; Natanson C
    Intensive Care Med; 2008 Nov; 34(11):1955-60. PubMed ID: 18839140
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacological treatment of sepsis.
    Girbes AR; Beishuizen A; Strack van Schijndel RJ
    Fundam Clin Pharmacol; 2008 Aug; 22(4):355-61. PubMed ID: 18705746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Questionable efficacy and safety of activated drotrecogin alpha (activated protein C) in the treatment of severe sepsis].
    Girbes AR; Polderman KH; Beishuizen A; van Zanten AR; Schultz MJ
    Ned Tijdschr Geneeskd; 2006 Jun; 150(22):1265-6; author reply 1266. PubMed ID: 16796179
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.